References
- TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
- BruixJShermanMManagement of hepatocellular carcinomaHepatology20054251208123616250051
- FengMBen-JosefERadiation therapy for hepatocellular carcinomaSemin Radiat Oncol201121427127721939856
- Clinical TrialsTianjin Medical University Cancer Institute and Hospital: Study on effectiveness and safety of hepatocellular carcinoma patients treated with CyberKnife: Trial record 1 of 1 for: NCT02363218 [update October 5, 2016; cited May 18, 2017] Available from: https://clinicaltrials.gov/ct2/show/NCT02363218?term=NCT02363218&rank=1. NLM identifier: NCT02363218Accessed May 20, 2017
- BujoldAMasseyCAKimJJSequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinomaJ Clin Oncol201331131631163923547075
- PanCCKavanaghBDDawsonLARadiation-associated liver injuryInt J Radiat Oncol Biol Phys2010763 supplS94S10020171524
- CaoYWangHJohnsonTDPrediction of liver function by using magnetic resonance-based portal venous perfusion imagingInt J Radiat Oncol Biol Phys201385125826322520476
- RusthovenKEKavanaghBDCardenesHMulti-institutional phase I/II trial of stereotactic body radiation therapy for liver metastasesJ Clin Oncol200927101572157819255321
- HøyerMSwaminathABydderSRadiotherapy for liver metastases: a review of evidenceInt J Radiat Oncol Biol Phys20128231047105722284028
- GoodmanKAWiegnerEAMaturenKEDose-escalation study of single-fraction stereotactic body radiotherapy for liver malignanciesInt J Radiat Oncol Biol Phys201078248649320350791
- EriguchiTTakedaASanukiNAcceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary systemInt J Radiat Oncol Biol Phys20138541006101123102838
- van der PoolAEMMéndez RomeroAWunderinkWStereotactic body radiation therapy for colorectal liver metastasesBr J Surg201097337738220095016
- WulfJGuckenbergerMHaedingerUStereotactic radiotherapy of primary liver cancer and hepatic metastasesActa Oncol200645783884716982548
- DawsonLAHaken TenRKLawrenceTSPartial irradiation of the liverSemin Radiat Oncol20011240246
- GuhaCKavanaghBDHepatic radiation toxicity: avoidance and ameliorationSemin Radiat Oncol201121425626321939854
- SonSHChoiBORyuMRStereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complicationInt J Radiat Oncol Biol Phys20107841073108020207492
- LiangSXZhuXDXuZYRadiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation toleranceInt J Radiat Oncol Biol Phys200665242643416690430
- ChengJCWuJKHuangCMRadiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implicationInt J Radiat Oncol Biol Phys200254115616212182986
- LawrenceTSRobertsonJMAnscherMSJirtleRLEnsmingerWDFajardoLFHepatic toxicity resulting from cancer treatmentInt J Radiat Oncol Biol Phys1995315123712487713785
- ParkHCSeongJHanKHChonCYMoonYMSuhCODose response relationship in local radiotherapy for hepatocellular carcinomaInt J Radiat Oncol Biol Phys200254115015512182985
- KwonJHBaeSHKimJYLong-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancerBMC Cancer20101011020047689
- AndolinoDLJohnsonCSMaluccioMStereotactic body radiotherapy for primary hepatocellular carcinomaInt J Radiat Oncol Biol Phys2011814e447e45321645977
- WadaHTakaiYNemotoKYamadaSUnivariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumorsInt J Radiat Oncol Biol Phys20045841114112015001252